SPACs Today: Thursday, Dec 1

by | Dec 1, 2022

Chart of the Day

Pacifico Acquisition Corp. (PAFO) shares ticked up today after the company disclosed a 99.6% redemption rate on its merger vote with Caravelle. With little other optimism in the SPAC market, savvy traders are still looking to make quick returns on low-float depleted trust SPACs.

Elsewhere Today in SPACs

  • Iris Acquisition Corp. (IRAA) and Liminatus Pharma agreed to a definitive agreement valued at $334M EV
  • Pacifico Acquisition Corp. (PAFO) shareholders approved Caravelle deal, but not before 99.6% of shareholders elected to redeem at the merger vote
  • Sky Venture looks to be headed towards a dispute with Primavera Capital Acquisition Corp. (PV) as they attempt to get out of their $40M committed FPA
  • Canna-Global (CNGL) shareholders approved a 12-month (on a monthly basis) extension out till December of 2023, though 90% of the trust redeemed and just $24M remains in the account
  • Brad Gerstner’s Altimeter Growth Corp. II (AGCB) will liquidate at $10.11 on December 21
  • One Equity Partners Open Water I Corp. (OEPW) shareholders approved its early liquidation and the SPAC will wind down on December 8th
  • Atlas Crest Investment Corp. II (ACII) voters approved early termination and set today, December 1st, as its termination date

SPAC Calendar

Today’s SPAC Movers

Biggest Gainers

3.40% ~ $ 9.72 | VENA – Venus Acquisition Corporation (Announced)
1.46% ~ $ 10.45 | LAAA – Lakeshore Acquisition I Corp. (Announced)
.99% ~ $ 10.24 | VSAC – VISION SENSING ACQUISITION CORP. (Announced)
.79% ~ $ 10.18 | ACAC – Acri Capital Acquisition Corp (Pre-Deal)
.69% ~ $ 10.16 | TWND – Tailwind Acquisition Corp (Announced)
.69% ~ $ 10.27 | IOAC – Innovative International Acquisition Corp. (Announced)
.60% ~ $ 10.12 | FLFV – Feutune Light Acquisition Corp (Pre-Deal)
.59% ~ $ 10.15 | GATE – Marblegate Acquisition Corp. (Pre-Deal)
.59% ~ $ 10.16 | MPRA – Mercato Partners Acquisition Corp (Pre-Deal)
.57% ~ $ 10.52 | PNAC – Prime Number Acquisition I Corp. (Pre-Deal)
.50% ~ $ 10.04 | AMAO – American Acquisition Opportunity Inc (Announced)
.50% ~ $ 10.05 | SGHL – Signal Hill Acquisition Corp. (Pre-Deal)
.50% ~ $ 10.07 | TLGA – TLG Acquisition One Corp. (Announced)
.49% ~ $ 10.20 | BPAC – Bullpen Parlay Acquisition Co (Pre-Deal)
.49% ~ $ 10.21 | IQMD – Intelligent Medicine Acquisition Corp. (Pre-Deal)
.49% ~ $ 10.27 | JMAC – Maxpro Capital Acquisition Corp. (Announced)
.49% ~ $ 10.28 | GGAA – Genesis Growth Tech Acquisition Corp. (Announced)
.48% ~ $ 10.49 | DKDCA – Data Knights Acquisition Corp. (Announced)
.45% ~ $ 9.99 | BSAQ – Black Spade Acquisition Co (Pre-Deal)
.44% ~ $ 10.26 | CMCA – Capitalworks Emerging Markets Acquisition Corp (Pre-Deal)

Recent Analysis


The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon. 

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.  

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by BA that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.  

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.